Ionis Pharmaceuticals (IONS) PT Raised to $125 at H.C. Wainwright
April 30, 2026 6:50 AM
H.C. Wainwright analyst Mitchell Kapoor raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $125.00 (from $120.00) while maintaining a Buy rating.
